ABCL vs. MSTY
ABCL (AbCellera Biologics Inc.) is a stock, while MSTY (YieldMax™ MSTR Option Income Strategy ETF) is Derivative Income fund actively managed by YieldMax. Over the past year, ABCL returned 62.59% vs -73.76% for MSTY. At a 0.34 correlation, their price movements are largely independent.
Performance
ABCL vs. MSTY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABCL achieves a 90.64% return, which is significantly higher than MSTY's -35.55% return.
ABCL
- 1D
- -4.12%
- 1M
- 24.43%
- 6M
- 44.25%
- YTD
- 90.64%
- 1Y
- 62.59%
- 3Y*
- -3.07%
- 5Y*
- -17.32%
- 10Y*
- —
MSTY
- 1D
- -2.03%
- 1M
- -23.27%
- 6M
- -39.01%
- YTD
- -35.55%
- 1Y
- -73.76%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ABCL vs. MSTY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ABCL AbCellera Biologics Inc. | 90.64% | 16.72% | -39.09% |
MSTY YieldMax™ MSTR Option Income Strategy ETF | -35.55% | -42.71% | 212.16% |
Correlation
The correlation between ABCL and MSTY is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.34 |
Correlation (All Time) Calculated using the full available price history since Feb 22, 2024 | 0.35 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABCL vs. MSTY — Risk / Return Rank
ABCL
MSTY
ABCL vs. MSTY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and YieldMax™ MSTR Option Income Strategy ETF (MSTY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ABCL | MSTY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.94 | ||
| Sortino ratioReturn per unit of downside risk | +3.97 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 0.75 | +0.43 |
| Calmar ratioReturn relative to maximum drawdown | 1.15 | -0.95 | +2.10 |
| Martin ratioReturn relative to average drawdown | 2.07 | -1.41 | +3.49 |
Loading charts...
Drawdowns
ABCL vs. MSTY - Drawdown Comparison
The maximum ABCL drawdown since its inception was -96.84%, which is greater than MSTY's maximum drawdown of -77.40%. Use the drawdown chart below to compare losses from any high point for ABCL and MSTY.
Loading charts...
Drawdown Indicators
| ABCL | MSTY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.84% | -77.40% | -19.44% |
Max Drawdown (1Y)Largest decline over 1 year | -54.94% | -77.40% | +22.46% |
Max Drawdown (3Y)Largest decline over 3 years | -75.72% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -90.96% | — | — |
Current DrawdownCurrent decline from peak | -89.31% | -74.66% | -14.65% |
Average DrawdownAverage peak-to-trough decline | -84.20% | -28.01% | -56.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.29% | 52.19% | -21.90% |
Volatility
ABCL vs. MSTY - Volatility Comparison
AbCellera Biologics Inc. (ABCL) has a higher volatility of 25.44% compared to YieldMax™ MSTR Option Income Strategy ETF (MSTY) at 23.76%. This indicates that ABCL's price experiences larger fluctuations and is considered to be riskier than MSTY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABCL | MSTY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.44% | 23.76% | +1.68% |
Volatility (6M)Calculated over the trailing 6-month period | 57.96% | 53.06% | +4.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 79.28% | 64.61% | +14.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.47% | 72.32% | -4.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 70.67% | 72.32% | -1.65% |
Dividends
ABCL vs. MSTY - Dividend Comparison
ABCL has not paid dividends to shareholders, while MSTY's dividend yield for the trailing twelve months is around 289.43%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
ABCL AbCellera Biologics Inc. | 0.00% | 0.00% | 0.00% |
MSTY YieldMax™ MSTR Option Income Strategy ETF | 289.43% | 294.61% | 104.56% |
Frequently Asked Questions
ABCL and MSTY have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABCL has higher volatility (25.44%) compared to MSTY (23.76%). In terms of maximum drawdown, ABCL dropped -96.84% vs MSTY's -77.40%.
ABCL currently has the higher Sharpe Ratio (0.80 vs -1.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABCL and MSTY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer